Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment
Abstract Background Cardiovascular disease (CVD) is a major cause of mortality worldwide, necessitating more refined strategies for risk assessment. Recently, lipoprotein(a) [Lp(a)] has gained attention for its distinctive role in atherosclerosis, yet its prevalence and impact for cardiovascular ris...
Saved in:
Main Authors: | Miguel Saraiva, Jonatas Garcez, Beatriz Tavares da Silva, Inês Poças Ferreira, José Carlos Oliveira, Isabel Palma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-025-02433-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
by: Tessa M. Zeis, MD, et al.
Published: (2025-03-01) -
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin
by: Craig A. Swearingen, et al.
Published: (2025-01-01) -
Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018
by: Yan Jiang, et al.
Published: (2025-01-01) -
ABNORMAL BLOOD LIPIDS LEVELS (DYSLIPIDEMIA) TREATMENT WITH ACUPUNCTURE METHOD
by: Anissa Maulina Rinjani, et al.
Published: (2022-03-01) -
Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
by: Yan Qin, et al.
Published: (2024-12-01)